HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabriel Núñez Selected Research

Particulate Matter

10/2014Cytosolic double-stranded RNA activates the NLRP3 inflammasome via MAVS-induced membrane permeabilization and K+ efflux.
7/2009Cutting edge: TNF-alpha mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gabriel Núñez Research Topics

Disease

35Infections
01/2023 - 11/2006
28Inflammation (Inflammations)
01/2024 - 02/2003
6Colitis
01/2024 - 12/2013
6Neoplasms (Cancer)
10/2021 - 12/2011
5Cryopyrin-Associated Periodic Syndromes
11/2020 - 03/2003
5Bacterial Infections (Bacterial Infection)
02/2017 - 06/2007
5Salmonella Infections (Salmonellosis)
03/2016 - 06/2006
4Dysbiosis
03/2024 - 01/2014
4Crohn Disease (Crohn's Disease)
12/2023 - 09/2011
4Sepsis (Septicemia)
02/2017 - 09/2011
4Virus Diseases (Viral Diseases)
04/2015 - 12/2006
3Skin Diseases (Skin Disease)
01/2018 - 07/2012
3Macular Degeneration (Age-Related Maculopathy)
06/2015 - 05/2012
3Melanoma (Melanoma, Malignant)
10/2014 - 05/2013
3Necrosis
10/2014 - 03/2006
3Carcinogenesis
12/2013 - 12/2008
3Familial Mediterranean Fever (Periodic Disease)
05/2011 - 03/2003
2Atopic Dermatitis (Atopic Eczema)
03/2024 - 11/2013
2Atherosclerosis
11/2020 - 03/2015
2Alzheimer Disease (Alzheimer's Disease)
11/2020 - 03/2015
2Type 2 Diabetes Mellitus (MODY)
11/2020 - 03/2015
2Pneumonia (Pneumonitis)
01/2016 - 06/2007
2Periodontitis
01/2016 - 05/2013
2Shock
11/2015 - 12/2014
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2014 - 12/2011
2Wounds and Injuries (Trauma)
06/2013 - 09/2011
2Pseudomembranous Enterocolitis (Pseudomembranous Colitis)
09/2012 - 04/2011
1IgG Deficiency
10/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Candidiasis (Moniliasis)
01/2022
1Communicable Diseases (Infectious Diseases)
01/2022
1Listeriosis (Listeria Infection)
01/2022
1Obesity
01/2022
1Coinfection
12/2021
1Malaria
12/2021
1Glioma (Gliomas)
10/2021
1Respiratory Syncytial Virus Infections
01/2021

Drug/Important Bio-Agent (IBA)

29InflammasomesIBA
01/2023 - 12/2006
14Proteins (Proteins, Gene)FDA Link
01/2023 - 02/2003
14CytokinesIBA
01/2021 - 12/2008
8NLR ProteinsIBA
01/2017 - 06/2007
8NucleotidesIBA
01/2017 - 06/2006
6Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 10/2008
6LipopolysaccharidesIBA
10/2020 - 06/2006
6NF-kappa B (NF-kB)IBA
05/2010 - 03/2003
5IronIBA
01/2024 - 06/2015
5Interleukin-18 (Interleukin 18)IBA
11/2018 - 12/2006
5Adenosine Triphosphate (ATP)IBA
10/2014 - 06/2007
4Immunoglobulin G (IgG)IBA
10/2022 - 05/2015
4Dextran SulfateIBA
10/2022 - 06/2011
4InterleukinsIBA
11/2020 - 12/2006
4Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
04/2015 - 03/2010
4Interleukin-6 (Interleukin 6)IBA
10/2014 - 03/2006
4FlagellinIBA
06/2013 - 11/2006
3Interleukin-17 (Interleukin 17)IBA
01/2022 - 11/2017
3Virulence Factors (Pathogenicity Factors)IBA
01/2018 - 11/2009
3Interleukin-22 (IL-22)IBA
02/2017 - 10/2014
3Interleukin-10 (Interleukin 10)IBA
12/2014 - 01/2012
3Poly I-CIBA
10/2014 - 12/2006
3Pattern Recognition ReceptorsIBA
10/2014 - 06/2006
3ChemokinesIBA
10/2014 - 02/2009
3Toll-Like Receptors (Toll-Like Receptor)IBA
06/2014 - 09/2008
3PyrinIBA
05/2011 - 03/2003
2AntigensIBA
10/2022 - 11/2013
2N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
01/2021 - 03/2015
2Particulate MatterIBA
10/2014 - 07/2009
2Leucine (L-Leucine)FDA Link
02/2014 - 05/2009
2Peptidoglycan (Murein)IBA
05/2013 - 02/2009
2Double-Stranded RNA (RNA, Double Stranded)IBA
05/2013 - 12/2006
2CaspasesIBA
07/2009 - 12/2006
2Interleukin-1beta (Interleukin 1 beta)IBA
01/2009 - 12/2008
2Mitogen-Activated Protein KinasesIBA
06/2006 - 03/2006
1Single-Domain AntibodiesIBA
01/2024
1AntibodiesIBA
01/2024
1SteroidsIBA
12/2023
1OMPA outer membrane proteinsIBA
10/2022
1Listeria monocytogenes hlyA protein (listeriolysin O)IBA
01/2022
1bis(3',5')-cyclic diguanylic acidIBA
01/2022
1Amino AcidsFDA Link
01/2022
1Arabinose (L-Arabinose)IBA
01/2022
1Chelating AgentsIBA
01/2022
1MonosaccharidesIBA
01/2022
1Sucrase (Sucrose alpha-D-Glucohydrolase)IBA
01/2022
1Sucrose (Saccharose)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
10/2021
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
10/2021
1Histone DemethylasesIBA
10/2021
1alpha-hydroxyglutarateIBA
10/2021
1DNA (Deoxyribonucleic Acid)IBA
10/2021
1TamoxifenFDA LinkGeneric
01/2021
1Antimicrobial PeptidesIBA
01/2021
1Complement C3 (C3 Complement)IBA
10/2020
1lipoteichoic acidIBA
11/2018
1solonamide BIBA
01/2018

Therapy/Procedure

2Immunotherapy
10/2021 - 01/2021
2Therapeutics
01/2018 - 01/2017
2Ligation
01/2016 - 12/2014
1Skin Care
03/2024
1Enteral Nutrition (Feeding, Tube)
12/2023